Results 61 to 70 of about 254,141 (317)
Objectives This study aims to describe the frequency and timing of physician referrals to physical therapists (PT) and other treatments prescribed over 12 months in patients with recent onset of knee osteoarthritis (KOA). The study also aims to identify determinants of early PT referrals.
Samannaaz S. Khoja +4 more
wiley +1 more source
We sought to clarify the musculoskeletal ultrasound (MSUS) findings and serum concentrations of cytokines/growth factors in glucocorticoid-resistant polymyalgia rheumatica (GC-R PMR).
Tomoki Origuchi +11 more
doaj +1 more source
Objective We assessed whether circulating adipokines are associated with incident fractures in patients with rheumatoid arthritis (RA). Methods Three adipokines (adiponectin, leptin, and fibroblast growth factor [FGF]‐21) were measured using banked enrollment serum from participants in a longitudinal RA cohort.
Joshua F. Baker +9 more
wiley +1 more source
Case Report: Pyoderma gangrenosum misdiagnosed as diabetic foot
Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis characterized by pain and sterile ulcers. PG in diabetic patients is uncommon and often misdiagnosed as diabetic foot.
Juyun Zhang +3 more
doaj +1 more source
The SRSF4–GAS5-Glucocorticoid Receptor Axis Regulates Ventricular Hypertrophy [PDF]
Javier Larrasa-Alonso +10 more
openalex +1 more source
Glucocorticoids and Cancer [PDF]
Unlike other steroid hormone receptors, the glucocorticoid receptor (GR) is not considered an oncogene. In breast cancer, the estrogen receptor (ER) drives cell growth, proliferation, and metastasis, and the androgen receptor (AR) plays a similar role in prostate cancer.
openaire +2 more sources
A Twist in the Diagnosis: Chronic Arthropathy Without Inflammation
Arthritis Care &Research, EarlyView.
María Á. Puche‐Larrubia +3 more
wiley +1 more source
Recently, there has been growing discussion about how to best assess pain in clinical trials in rheumatic diseases. Reliable measurement of pain outcomes is essential for accurately determining the effectiveness of treatments. Although pain intensity is the most common measure of change in pain trials, other pain‐related measures, such as pain ...
Yen T. Chen +4 more
wiley +1 more source
Objective This study aimed to identify in patients with systemic lupus erythematosus (SLE) with clinically active disease the attainment of frequency and determinants of Lupus Low Disease Activity State (LLDAS) and Definition of Remission in SLE (DORIS) and the frequency and determinants of flare and damage accrual after target attainment.
Yanjie Hao +39 more
wiley +1 more source
Objective The objective was to identify factors determining acute arthritis resolution and safety with colchicine and prednisone in acute calcium pyrophosphate (CPP) crystal arthritis. Methods We conducted a post hoc analysis of the COLCHICORT trial, which compared colchicine and prednisone for the treatment of acute CPP crystal arthritis, using a ...
Tristan Pascart +14 more
wiley +1 more source

